Compound: PD173074

Drug Target: FGFR1, FGFR2, FGFR3

Drug Target pathway: RTK signaling

DatasetDatasets
GDSC1: Screened in 96 or 384-well plates with Cyto60 or Resazurin endpoint
GDSC2 (recommended where available): 1536-well plates with CellTiterGlo endpoint
See documentation for more information and screening differences



Tissue specific analysis

PD173074 IC50 values for cnaPANCAN387

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.